Polyrizon CEO sells 3,900 shares in open-market trade

Polyrizon Ltd. Chief Executive Officer Tomer Izraeli reported an open-market sale of 3,900 Ordinary Shares on March 30, 2026 at $10.90 per share.

Rhea-AI Filing Summary

Polyrizon Ltd. Chief Executive Officer Tomer Izraeli reported an open-market sale of 3,900 Ordinary Shares on March 30, 2026 at $10.90 per share. After this transaction, he directly holds 32,012 Ordinary Shares.

According to the footnote, his holdings consist of 6,959 ordinary shares and 25,053 restricted ordinary shares. The restricted shares vest in equal installments, with 53 shares vesting monthly and 25,000 shares vesting quarterly, in each case subject to his continued service.

Insider Trade Summary

Net Seller: 3,900 shares

Net Sell 1 txn

Insider Izraeli Tomer

Role Chief Executive Officer

Sold 3,900 shs ($43K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	3,900	$10.90	$43K

Holdings After Transaction: Ordinary Shares — 32,012 shares (Direct)

Footnotes (1)

1. F1. Consists of (1) 6,959 ordinary shares, (2) 53 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (3) 25,000 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.

Key Figures

Shares sold: 3,900 shares Sale price: $10.90 per share Shares held after transaction: 32,012 shares +3 more

6 metrics

Shares sold 3,900 shares Ordinary Shares sold on March 30, 2026

Sale price $10.90 per share Price for the 3,900 Ordinary Shares sold

Shares held after transaction 32,012 shares Direct Ordinary Share holdings following the sale

Unrestricted ordinary shares 6,959 shares Portion of CEO’s holdings that are ordinary shares

Restricted shares vesting monthly 53 shares Restricted ordinary shares vesting in equal monthly installments

Restricted shares vesting quarterly 25,000 shares Restricted ordinary shares vesting in equal quarterly installments

Key Terms

open-market sale, restricted ordinary shares, vest in equal installments, continued service

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

restricted ordinary shares financial

"Consists of (1) 6,959 ordinary shares, (2) 53 restricted ordinary shares"

Restricted ordinary shares are common stock that cannot be sold or transferred until certain conditions are met—such as a time period passing, performance targets being reached, or regulatory approvals—often issued to employees, founders, or early investors. They matter because those restrictions delay when the shares can enter the market, affecting the future supply of shares, potential dilution and company valuation; think of them as goods locked in a warehouse until release conditions are satisfied.

vest in equal installments financial

"restricted ordinary shares that vest in equal installments on a monthly basis"

continued service financial

"subject to the Reporting Person's continued service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Polyrizon (PLRZ) CEO Tomer Izraeli report?

Polyrizon CEO Tomer Izraeli reported an open-market sale of 3,900 Ordinary Shares at $10.90 per share. The transaction involved non-derivative Ordinary Shares and was classified as a sale in the open market or a private transaction.

How many Polyrizon (PLRZ) shares does the CEO hold after the reported sale?

After selling 3,900 Ordinary Shares, CEO Tomer Izraeli directly holds 32,012 Ordinary Shares. This total includes both unrestricted and restricted shares, as detailed in the filing’s footnote regarding the composition and vesting of his equity holdings.

What was the price per share in the Polyrizon (PLRZ) CEO’s Form 4 sale?

The reported sale by Polyrizon CEO Tomer Izraeli was executed at $10.90 per Ordinary Share. This price applies to the 3,900 shares sold in the open-market transaction, as disclosed in the Form 4 insider trading data.

How are the Polyrizon (PLRZ) CEO’s restricted shares structured and vesting?

The CEO’s holdings include 53 restricted ordinary shares vesting in equal monthly installments and 25,000 restricted ordinary shares vesting in equal quarterly installments. Both vesting schedules are subject to his continued service with the company, according to the footnote.

What portion of the Polyrizon (PLRZ) CEO’s holdings are unrestricted ordinary shares?

Out of the CEO’s 32,012 Ordinary Shares, 6,959 are unrestricted ordinary shares. The remainder are restricted ordinary shares that vest over time, combining the monthly and quarterly vesting grants described in the Form 4 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Izraeli Tomer

(Last) (First) (Middle)

C/O POLYRIZON LTD.

9 HAPNINA STREET

(Street)

RAANANA 4321546

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/30/2026		S		3,900	D	$10.9	32,012(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of (1) 6,959 ordinary shares, (2) 53 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (3) 25,000 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.

	/s/ Tomer Izrael	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)